AstraZeneca CEO projects $80B revenue by 2030, driven by 20 new drugs, with half treating cancer.

AstraZeneca CEO Pascal Soriot projects that the company can nearly double its revenue to $80 billion by 2030, driven by the launch of 20 new drugs, with half treating cancer. The firm's recent results showed a 26% growth in its oncology business, which reached $5 billion for the first time. Soriot attributes this growth to scientific advancements and believes that the day of curing cancer may not be far away.

Articles

NBC DFW

CNBC

NBC Philadelphia

NBC 7 San Diego

Biztoc

NBC Connecticut

-- show less --

Further Reading

Related Stories